West Pharmaceutical Services, Inc.
336.94USD
-0.8100 (-0.24%)
Fetching financial statements from SEC filings…
| In $M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25* | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* | Q3 FY24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 872 | 845 | 805 | 805 | 767 | 698 | 749 | 747 |
| Cost of Revenue | 543 | 549 | 501 | 510 | 493 | 466 | 475 | 482 |
| Gross Profit | 329 | 296 | 304 | 294 | 274 | 232 | 274 | 265 |
| Operating Income | 179 | 177 | 157 | 168 | 154 | 107 | 160 | 161 |
| Net Income | 154 | 139 | 132 | 140 | 132 | 90 | 130 | 136 |
| EPS (Diluted) | $2.15 | $1.92 | $1.82 | $1.92 | $1.82 | $1.23 | $1.78 | $1.85 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)